|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Interest-bearing deposits in banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Certificates of deposit in banks | ||||||||||||||||||||
| Securities held-to-maturity, at amortized cost (fair value of $95,583 and $98,260, respectively) | ||||||||||||||||||||
| Securities available-for-sale, at fair value (amortized cost of $731,514 and $670,980, respectively) | ||||||||||||||||||||
| Loans held for sale | ||||||||||||||||||||
| Loans, net of deferred fees and discounts | ||||||||||||||||||||
| Less allowance for credit losses | ||||||||||||||||||||
| Net loans | ||||||||||||||||||||
| Premises and equipment, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Bank owned life insurance | ||||||||||||||||||||
| Foreclosed assets | ||||||||||||||||||||
| Deferred income taxes, net | ||||||||||||||||||||
| Core deposit intangible | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Restricted equity securities, at cost | ||||||||||||||||||||
| Affordable housing tax credit investments | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Shareholders' Equity | ||||||||||||||||||||
| Noninterest-bearing deposits | ||||||||||||||||||||
| Interest-bearing deposits | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Securities sold under agreements to repurchase | ||||||||||||||||||||
| Federal Home Loan Bank advances | ||||||||||||||||||||
| Federal funds purchased | ||||||||||||||||||||
| Subordinated debentures, net of loan costs | ||||||||||||||||||||
| Accrued interest payable and other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Common stock related to 401(k) Employee Stock Ownership Plan | ||||||||||||||||||||
| Stockholders' Equity | ||||||||||||||||||||
| Common stock ($1 par value; 15,000,000 shares authorized; 7,879,841 and 7,798,639 shares issued; 7,816,249 and 7,745,983 shares outstanding at June 30, 2026 and December 31, 2025, respectively) | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Unvested restricted stock | ||||||||||||||||||||
| Treasury stock at cost (63,592 and 52,656 shares, respectively) | ||||||||||||||||||||
| Common stock related to 401(k) Employee Stock Ownership Plan | ||||||||||||||||||||
| Total stockholders' equity | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and stockholders' equity | ||||||||||||||||||||
Loading...
